|
Re: Reverse Split, the good, bad and in between....
|
1
|
Resverlogix Corp.
|
Aug 15, 2018 12:26PM
|
|
Re: Reverse Split, the good, bad and in between....
|
1
|
Resverlogix Corp.
|
Aug 15, 2018 09:38PM
|
|
Re: Resverlogix Reschedules Update Webcast and Conference Call: Now February 4th 10AM MT
|
7
|
Resverlogix Corp.
|
Jan 27, 2021 08:52PM
|
|
Re: Resverlogix Reschedules Update Webcast and Conference Call: Now February 4th 10AM MT
|
6
|
Resverlogix Corp.
|
Jan 27, 2021 09:00PM
|
|
Re: Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial
|
6
|
Resverlogix Corp.
|
Feb 23, 2017 10:47AM
|
|
Re: Resverlogix poster from ASN 2016
|
1
|
Resverlogix Corp.
|
Nov 21, 2016 06:10PM
|
|
Re: Resverlogix NYAS Symposium notes
|
4
|
Resverlogix Corp.
|
Apr 29, 2016 04:11PM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
9
|
Resverlogix Corp.
|
Nov 01, 2021 10:22AM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
8
|
Resverlogix Corp.
|
Nov 01, 2021 10:38AM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
8
|
Resverlogix Corp.
|
Nov 01, 2021 12:07PM
|
|
Re: RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL
|
3
|
Resverlogix Corp.
|
Mar 19, 2018 10:09AM
|
|
Re: Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
6
|
Resverlogix Corp.
|
Oct 26, 2015 02:16PM
|
|
Re: Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
7
|
Resverlogix Corp.
|
Nov 12, 2015 12:54PM
|
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
6
|
Resverlogix Corp.
|
Jun 20, 2017 10:30AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 09:42AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
9
|
Resverlogix Corp.
|
Jun 22, 2022 03:41PM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
7
|
Resverlogix Corp.
|
Apr 11, 2018 08:54AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
6
|
Resverlogix Corp.
|
Apr 11, 2018 09:53AM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
2
|
Resverlogix Corp.
|
Nov 17, 2016 07:17PM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
2
|
Resverlogix Corp.
|
Nov 17, 2016 10:42AM
|
